Selective occlusion of choroidal neovascularization by photodynamic therapy with a water-soluble photosensitizer, ATX-S10

Lasers in Surgery and Medicine

Volumn 24, Issue 3, 1999, Pages 209-222

  Obana, Akira ^a   Gohto, Yuko ^a   Kaneda, Kenji ^a   Nakajima, Susumu ^b   Takemura, Takeshi ^c   Miki, Tokuhiko ^a  

^a OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b ASAHIKAWA MEDICAL COLLEGE   (Japan)

^c HOKKAIDO UNIVERSITY   (Japan)

Author keywords

ATX S10; Choroidal neovascularization; Photodynamic therapy; Selective occlusion; Treatment parameters

Indexed keywords

13,17 BIS(1 CARBOXYPROPIONYL)CARBAMOYLETHYL 8 ETHENYL 2 HYDROXY 3 HYDROXYIMINOETHYLIDENE 2,7,12,18 TETRAMETHYLPORPHYRIN SODIUM; 13,17 BISPROPIONYLASPARTIC ACID 3 ETHENYL 7 HYDROXY 8 HYDROXYIMINOETHYLIDENE 2,7,12,18 TETRAMETHYLPORPHINE; PHOTOSENSITIZING AGENT; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD VESSEL OCCLUSION; CONTROLLED STUDY; DIODE LASER; ELECTRON MICROSCOPY; FLUORESCENCE ANGIOGRAPHY; FLUORESCENCE MICROSCOPY; NONHUMAN; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; RADIATION DOSE; RAT; RETINA CAPILLARY; SUBRETINAL NEOVASCULARIZATION; TISSUE INJURY;

ANIMALS; CHOROID; CHOROIDAL NEOVASCULARIZATION; DISEASE MODELS, ANIMAL; FLUORESCEIN ANGIOGRAPHY; FUNDUS OCULI; INJECTIONS, INTRAVENOUS; LASER COAGULATION; MICROSCOPY, FLUORESCENCE; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS; PORPHYRINS; RATS; RATS, LONG-EVANS; RETINA; TREATMENT OUTCOME;

EID: 0032908193     PISSN: 01968092     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-9101(1999)24:3<209::AID-LSM6>3.0.CO;2-L     Document Type: Article

References (34)

1. Macular Photocoagulation Study Group. Argon laser photocoagulation for neovascular maculopathy. Three-year results from randomized clinical trials. Arch Ophthalmol 1986;104:694-701.
2. Macular Photocoagulation Study Group. Krypton laser photocoagulation for neovascular lesions of age-related macular degeneration. Results of a randomized clinical trial. Arch Ophthalmol 1990;108:816-824.
3. Macular Photocoagulation Study Group. Laser photocoagulation of subfoveal neovascular lesions of age-related macular degeneration. Updated findings from two clinical trials. Arch Ophthalmol 1993;111:1200-1209.
4. Berenbaum MC, Hall GW, Hoyes AD. Cerebral photosensitization by haematoporphyrin derivative. Evidence for an endothelial site of action. Br J Cancer 1986;53:81-89.
5. Nelson JS, Liaw LH, Oresnstein A, Roberts WG, Berns MW. Mechanism of tumor destruction following photodynamic therapy with hematoporphyrin derivative, chlorine, and phthalocyanine. J Natl Cancer Inst 1988;80: 1599-1605.
6. Fingar VH, Wieman TJ, Wiehle SA, Cerrito PB. The role of microvascular damage in photodynamic therapy: the effect of treatment on vessel constriction, permeability, and leukocyte adhesion. Cancer Res 1992;52:4919-4921.
7. Packer AJ, Tse DT, Gu X-Q, Hayreh SS. Hematoporphyrin photoradiation therapy for iris neovascularization. A preliminary report. Arch Ophthalmol 1984;102:1193-1197.
8. Thomas EL, Langhofer M. Closure of experimental subretinal neovascular vessels with DHE augmented argon green laser photocoagulation. Photochem Photobiol 1987; 46:881-886.
9. Obana A, Gohto Y, Matsumoto M, Miki T. Photodynamic therapy of corneal neovascularization using hematoporphyrin derivatives. J Jpn Soc Laser Med 1996;17:31-43.
10. Huang AJN, Watson BD, Hernandez ZE, Tseng SCG. Photothrombosis of corneal neovascularization by intravenous rose bengal and argon laser irradiation. Arch Ophthalmol 1989;106:680-685.
11. Corrent G, Roussel TJ, Tseng SCG, Watson BD. Promotion of graft survival by photothrombotic occlusion of corneal neovascularization. Arch Ophthalmol 1989;107: 1501-1506.
12. Epstein RJ, Hendricks RL, Harris DM. Photodynamic terapy for corneal neovascularization. Cornea 1991;10: 424-432.
13. Pallikaris IG, Tslimbaris MK, Iliaki OE, Naoumidi II, Georgiades A, Panagopoulos IA. Effectivness of corneal neovascularization photothrombosis using phthalocyanine and a diode laser (675nm). Laser Surg Med 1993; 13:197-203.
14. Tsilimbaris MK, Pallikaris IG, Naoumidi II, Vlahonikolis IG, Tsakalof AK, Lydataki SE. Phthalocyanine mediated photodynamic thrombosis of experimental corneal neovascularization: effect of phthalocyanine dose and irradiation onset time on vascular occlusion rate. Laser Surg Med 1994;15:19-31.
15. Miller JW, Stinson WG, Gregory WA, El-Koumy HA, Puliafito CA. Phthalocyanine photodynamic therapy of experimental iris neovascularization. Ophthalmology 1991; 98:1711-1719.
16. Kliman GH, Puliafito CA, Stern D, Borirakchanyavat S, Gregory WA. Phthalocynanine photodynamic therapy: new strategy for closure of choroidal neovascularization. Laser Surg Med 1994;15:2-10.
17. Schmidt-Erfurth U, Hasan T, Gragoudas E, Michaud N, Flotte TJ, Birngruber R. Vascular targeting in photodynamic occlusion of subretinal vessels. Ophthalmology 1994;101:1953-1961.
18. Schmidt-Erfurth U, Hasan T, Schomacker K, Flotte TJ, Birngruber R. In vivo uptake of liposomal benzoporphyrin derivative and photothrombosis in experimental corneal neovascularization. Laser Surg Med 1995;17:178-188.
19. Miller JW, Walsh AW, Kramer M, et al. Photodynamic therapy of experimental choroidal neovascularization using lipoprotein-derived benzoporphyrin. Arch Ophthalmol 1995;113:810-818.
20. Kramer M, Miller JW, Michaud N, et al. Liposomal benzoporphyrin derivative verteporfin photodynamic therapy. Ophthalmology 1996;103:427-438.
21. Gragoudas ES, Schmidt-Erfurth U, Sickenberg M, et al. Results and preliminary dosimetry of photodynamic therapy for choroidal neovascularization in age-related macular degeneration in a phase I/II study. Invest Ophthalmol Vis Sci 1997;38:S17.
22. Thomas EL, Rosen R, Murphy R, et al. Purlytin™ (SnET2)-photodynamic therapy produces closure of subfoveal choroidal neovascularization in humans. Invest Ophthalmol Vis Sci 1998;39:S242.
23. Obana A, Miki T. Photocoagulation through retinal edema using three different wavelength lasers. Lasers Light Ophthalmol 1991;4:103-110.
24. Obana A, Miki T. Dye laser photocoagulation through experimental induced retinal hemorrhage. Lasers Surg Med 1991;11:152-157.
25. Nakajima S, Sakata I, Takemura T, et al. Tumor-localizing and photosensitization of photochlorin ATX-S10. In: Spinelli S, Fante D, Marchesini R, editors. Photodynamic therapy and biomedical lasers. Amsterdam: Elsevier; 1992. p 531-534.
26. Gohto Y, Obana A, Kaneda K, Miki T. Photodynamic effect of a new photosensitizer ATX-S10 on corneal neovascularization. Exp Eye Res (in press).
27. Tobe T, Takahashi K, Ohkuma H, Uyama M. Experimental choroidal neovascularization in the rat. J Jpn Ophthalmol Soc 1995;99:784-791.
28. Gohto Y, Obana A, Miki T, Kaneda K, Sakata I, Nakajima S. Mechanism of photodynamic effects of a photosensitizer (ATX-S10) on corneal neovascularization. ARVO abstracts. Invest Ophthalmol Vis Sci 1996;37: S547.
29. Gohto Y, Obana A, Miki T, Kaneda K, Nakajima S, Takemura T. Time course for the distribution of a photosensitizer (ATX-S10) to corneal neovascularization. ARVO abstracts. Invest Ophthalmol Vis Sci 1997;38:S513.
30. Kohno T, DeLaey JJ, Miki T. Detection of choroidal neovascularization in age-related macular degeneration using subtraction methods in indocyanine green angiography. Bull Soc Belg Ophthalmol 1995;259:81-88.
31. Gass JDM. Stereoscopic atlas of macular disease and treatment. 3rd ed. St Louis: CV Mosby; 1987. p 70-73.
32. Gomer CJ, Jester JV, Razum NJ, Szirth BC, Murphree AL. Photodynamic therapy of intraocular tumors: examination of hematoporphyrin derivative distribution and long-term damage in rabbit ocular tissue. Cancer Res 1985;45:3718-3725.
33. Haimovici R, Kramer M, Miller JW, et al. Localization of lipoprotein-delivered benzoporphyrin derivative in the rabbit eye. Curr Eye Res 1997;16:83-90.
34. Roberts WG, Berns MW. In vitro photosensitization 1. Cellular uptake and subcellular localization of mon-L-aspartyl chlorine e6, chloro-aluminum sulfonated phthalocyanine, and photofrin II. Lasers Surg Med 1989;9:90-101.